CCIA
PTGX icon

Campbell & Co Investment Adviser’s Protagonist Therapeutics PTGX Stock Holding History

Campbell & Co Investment Adviser’s Portfolio PTGX Stock Details PTGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-21,054
Closed -$1.84M – 1356
2025
Q4 		$1.84M Buy
+21,054
New +$1.72M 0.09% 357
2025
Q2 		– Sell
-19,015
Closed -$920K – 1406
2025
Q1 		$920K Buy
+19,015
New +$797K 0.07% 464
2024
Q2 		– Sell
-13,763
Closed -$398K – 1289
2024
Q1 		$398K Buy
+13,763
New +$374K 0.03% 803
2023
Q4 		– Sell
-56,577
Closed -$944K – 1292
2023
Q3 		$944K Buy
56,577
+36,019
+175% +$699K 0.11% 291
2023
Q2 		$568K Buy
+20,558
New +$515K 0.1% 370

Other funds holding PTGX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return